Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA weight-loss supplement alert grows

This article was originally published in The Tan Sheet

Executive Summary

The agency is now warning consumers about 72 tainted weight-loss supplement products, including Herbal Xenicol, Slimbionic and Xsvelten. In a March 20 announcement, FDA also expanded its alert to include the unapproved active pharmaceutical ingredients fenproporex, fluoxetine, furosemide and cetilistat, which has shown similar effects to those of orlistat in investigational trials. FDA said it inspected companies involved in selling illicit products and may issue warning letters and initiate seizure actions due to firms' "inadequate responses to recall requests." The agency faced criticism about its inability to deter illegal activity in the weight-loss supplement market (1"The Tan Sheet" Feb. 2, 2009, p. 9)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel